CClinicalTrials.gg
RecruitingNCT06467552Updated Jun 21, 2024

Effects of Nutritional Support on Postoperative Delirium

An interventional study of control group and Nucare Curact group in Postoperative Delirium, sponsored by Yonsei University. Recruiting at 1 site in Korea, Republic of. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-06-21.

Sponsored by Yonsei University · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
314
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

This study is a prospective, single-center, randomized controlled trial to compare whether applying nutritional supplementation therapy before and after surgery in elderly patients aged 65 years or older undergoing non-cardiac surgery can reduce the incidence of postoperative delirium.

02

Conditions studied

  • Postoperative Delirium
03

In context

Delirium

1,057 studies on the registry are indexed under Delirium; 238 are open to participants now.

This study's planned enrollment of 314 is above the median of 120 across 599 interventional studies indexed under Delirium.

Browse Delirium studies →

Lead sponsor

Yonsei University is the lead sponsor of 1,387 studies on the registry; 232 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Elderly patients aged 65 and above.
  • Patients undergoing non-cardiac major surgery in thoracic surgery, lung cancer surgery, multi-level spinal surgery in neurosurgery and orthopedics, or liver cancer surgery in hepatobiliary and pancreatic surgery, under general anesthesia with an expected surgery duration of 2 hours or more.
  • Patients scheduled for arterial catheterization.
  • Patients who are able to take oral intake from postoperative day #1.

Exclusion criteria

Exclusion Criteria:

  • Patients with uncontrolled systemic conditions such as diabetes, hypertension, renal disease, liver disease, and other systemic illnesses.
  • Those with visual impairment.
  • Patients with cognitive impairment based on the Mini-Mental State Examination for Dementia Screening criteria.
  • Individuals experiencing difficulty in communication.
  • Those diagnosed with neurological disorders (such as brain hemorrhage, stroke, brain tumor, dementia, Parkinson's disease, cognitive impairment, depression, etc.).
  • Patients diagnosed with alcohol or substance addiction.
  • Patients with cancelled scheduled surgeries.
  • Patients undergoing minor surgeries with expected anesthesia durations of less than 2 hours.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
314 participants (estimated)

Study arms

  • Active comparator
    control group

    The entire process is carried out according to Severance Hospital surgical protocols.

    Procedure: control group

  • Experimental
    intervention group

    The entire process is carried out according to Severance Hospital surgical protocols. The patients of control group will receive education from the research team about the importance of nutrition and exercise before and after surgery. In addition, the patients of control group will be instructed to take up to 4 doses of the nutritional supplement (Nucare Curact provided by DAESANG Wellife Inc.) per day for approximately 2 weeks before surgery and for about 4 weeks after surgery.

    Dietary Supplement: Nucare Curact group

Interventions

  • Procedurecontrol group

    The entire process is carried out according to Severance Hospital surgical protocols.

  • Dietary supplementNucare Curact group

    The entire process is carried out according to Severance Hospital surgical protocols. The patients of control group will receive education from the research team about the importance of nutrition and exercise before and after surgery. In addition, the patients of control group will be instructed to take up to 4 doses of the nutritional supplement (Nucare Curact provided by DAESANG Wellife Inc.) per day for approximately 2 weeks before surgery and for about 4 weeks after surgery.

06

What researchers measure

Primary outcomes

  1. incidence of postoperative delirium

    Confusion assessment methods(CAM) will be used for diagnosing delirium At least two times a day during the hospitalization period. Patients diagnosed with delirium using the CAM were evaluated for the duration, symptoms, and type of delirium (e.g., reduced awareness of the environment; poor cognitive skills; behavioral changes; and emotional disturbances). \*\* Confusion assessment methods(CAM) diagnostic algorism (positive or negative result, positive means delirium) CAM is considered positive if features 1 and 2 are present, with at least one of features 3 or 4. Below are the four criteria of features : 1. Acute onset and fluctuating course Determined by collateral history or repeated clinic assessment 2. Inattention Counting from 20-1 is a simple (if blunt) test for this 3. Disorganized thinking 4. Altered levels of consciousness

    Time frame: from postoperative day 0 to postoperative day 7

Secondary outcomes

  1. duration of delirium

    The Quality of Recovery-40 (QoR-40) : 40\~200(better recovery)

    Time frame: from postoperative day 0 to postoperative day 7

  2. type of delirium

    Time frame: from postoperative day 0 to postoperative day 7

  3. K-FRAIL for frailty

    The Korean version of the fatigue, resistance, ambulation, illnesses, and loss of weight (K-FRAIL) scale : 0(healthy)\~8(frail). A raw score is standardized. A lower score means cognitive dysfunction.

    Time frame: from postoperative day 0 to postoperative day 7

  4. GDS for depression

    Geriatric Depression Scale(GDS) : 0(normal)\~ 15(depression). A raw score is standardized. A lower score means cognitive dysfunction.

    Time frame: from postoperative day 0 to postoperative day 7

  5. ADL for independence

    Activities of Daily Living(ADL)-Barthel Index : 0(completely dependent )\~105( independent). A raw score is standardized. A lower score means cognitive dysfunction.

    Time frame: from postoperative day 0 to postoperative day 7

  6. SNSB-c for cognitive dysfunction

    Seoul Neuropsychological Screening Battery-Core(SNSB-C): total score is 617. A raw score is standardized. A lower score means cognitive dysfunction.

    Time frame: from postoperative day 0 to postoperative day 7

  7. QOR-40 for recovery

    The Quality of Recovery-40 (QoR-40) : 40\~200(better recovery)

    Time frame: from postoperative day 0 to postoperative day 7

  8. K-MoCA for cognitive dysfunction

    Korean-Montreal Cognitive Assessment(K-MoCA) : 0\~30, cognitive dysfunction\<23.

    Time frame: from postoperative day 0 to postoperative day 7

  9. IADL for independence

    Instrumental Activities of Daily Living(IADL)-Lawton-Brody Scale : 0\~8(complete independence).

    Time frame: from postoperative day 0 to postoperative day 7

07

Study locations

1 of 1 sites recruiting
  • Yonsei University Health system, Severance Hospital
    Seoul, 03722, Korea, Republic of
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 21, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06467552
Lead sponsor
Yonsei University
Responsible party
Sponsor
First posted
Jun 21, 2024
Start date
Jun 2024 (estimated)
Primary completion
May 12, 2028 (estimated)
Completion
May 12, 2028 (estimated)
Last update
Jun 21, 2024

Study contacts

Bon-Nyeo koo, MD
Contact
koobn@yuhs.ac
82-10-9982-4469

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion